Effects of maternal dietary exposure to cadmium during pregnancy on mammary cancer risk among female offspring

Journal of Carcinogenesis

Volumn 12, Issue , 2013, Pages

  Davis, Jennifer ^a   Khan, Galam ^a   Martin, Mary ^a   Hilakivi Clarke, Leena ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Androgen receptor; cadmium; estradiol; estrogen receptor; in utero exposure; mammary cancer; maternal diet; testosterone

Indexed keywords

ANDROGEN RECEPTOR; CADMIUM; ESTRADIOL; KI 67 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIRTH WEIGHT; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CELL PROLIFERATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ESTRADIOL BLOOD LEVEL; ESTRUS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY GLAND; MORPHOMETRICS; NONHUMAN; PREGNANCY; PROGENY; PROTEIN EXPRESSION; PUBERTY; RAT; TESTOSTERONE BLOOD LEVEL; TUMOR VOLUME; WEIGHT GAIN;

EID: 84893423575     PISSN: 09746773     EISSN: 14773163     Source Type: Journal    
DOI: 10.4103/1477-3163.114219     Document Type: Article

References (58)

1. Hilakivi-Clarke L, de Assis S. Fetal origins of breast cancer. Trends Endocrinol Metab 2006;17:340-8. (Pubitemid 44584730)
2. Kawaguchi H, Miyoshi N, Miyamoto Y, Souda M, Umekita Y, Yasuda N, et al. Effects of exposure period and dose of diethylstilbestrol on pregnancy in rats. J Vet Med Sci 2009;71:1309-15.
3. Rudel RA, Fenton SE, Ackerman JM, Euling SY, Makris SL. Environmental exposures and mammary gland development: State of the science, public health implications, and research recommendations. Environ Health Perspect 2011;119:1053-61.
4. Hoover RN, Hyer M, Pfeiffer RM, Adam E, Bond B, Cheville AL, et al. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 2011;365:1304-14.
5. Johnson MD, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, et al. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 2003;9:1081-4. (Pubitemid 37021790)
6. Martin MB, Voeller HJ, Gelmann EP, Lu J, Stoica EG, Hebert EJ, et al. Role of cadmium in the regulation of AR gene expression and activity. Endocrinology 2002;143:263-75. (Pubitemid 34056428)
7. Stoica A, Katzenellenbogen BS, Martin MB. Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol 2000;14:545-53. (Pubitemid 32260523)
8. Khan G, Penttinen P, Cabanes A, Foxworth A, Chezek A, Mastropole K, et al. Maternal flaxseed diet during pregnancy or lactation increases female rat offspring′s susceptibility to carcinogen-induced mammary tumorigenesis. Reprod Toxicol 2007;23:397-406. (Pubitemid 46628875)
9. Strumylaite L, Bogusevicius A, Abdrachmanovas O, Baranauskiene D, Kregzdyte R, Pranys D, et al. Cadmium concentration in biological media of breast cancer patients. Breast Cancer Res Treat 2011;125:511-7.
10. Gallagher CM, Chen JJ, Kovach JS. Environmental cadmium and breast cancer risk. Aging (Albany NY) 2010;2:804-14.
11. McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM, Newcomb PA. Cadmium exposure and breast cancer risk. J Natl Cancer Inst 2010;98:869-73. (Pubitemid 43923443)
12. Julin B, Wolk A, Bergkvist L, Bottai M, Akesson A. Dietary cadmium exposure and risk of postmenopausal breast cancer: A population-based prospective cohort study. Cancer Res 2012;72:1459-66.
13. Jorhem L, Astrand C, Sundstrm B, Baxter M, Stokes P, Lewis J, et al. Elements in rice from the Swedish market: 1. Cadmium, lead and arsenic (total and inorganic). Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2008;25:284-92.
14. Zeng F, Mao Y, Cheng W, Wu F, Zhang G. Genotypic and environmental variation in chromium, cadmium and lead concentrations in rice. Environ Pollut 2008;153:309-14. (Pubitemid 351509683)
15. Chaudri A, McGrath S, Gibbs P, Chambers B, Carlton-Smith C, Godley A, et al. Cadmium availability to wheat grain in soils treated with sewage sludge or metal salts. Chemosphere 2007;66:1415-23. (Pubitemid 44895348)
16. Ronco AM, Arguello G, Muoz L, Gras N, Llanos M. Metals content in placentas from moderate cigarette consumers: Correlation with newborn birth weight. Biometals 2005;18:233-41. (Pubitemid 40685246)
17. World Health Organization. Beryllium, cadmium, mercury, and exposures in the glass manufactoring industry. IARC evaluation on the carcinogeneic risk to humans. Vol. 58. Lyon, France: WHO, IARC. IARC Cancer; 1997.
18. Nishijo M, Tawara K, Honda R, Kuriwaki J, Nakagawa H, Tanebe K, et al. Cadmium and nutritional intake in pregnant Japanese women. Toxicol Lett 2004;148:171-6. (Pubitemid 38369219)
19. Akesson A, Berglund M, Schtz A, Bjellerup P, Bremme K, Vahter M. Cadmium exposure in pregnancy and lactation in relation to iron status. Am J Public Health 2002;92:284-7. (Pubitemid 34101443)
20. Bhattacharyya MH. Bioavailability of orally administered cadmium and lead to the mother, fetus, and neonate during pregnancy and lactation: An overview. Sci Total Environ 1983;28:327-42.
21. Kuriwaki J, Nishijo M, Honda R, Tawara K, Nakagawa H, Hori E, et al. Effects of cadmium exposure during pregnancy on trace elements in fetal rat liver and kidney. Toxicol Lett 2005;156:369-76. (Pubitemid 40342570)
22. Hilakivi-Clarke L, Clarke R, Onojafe I, Raygada M, Cho E, Lippman M. A maternal diet high in n-6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring. Proc Natl Acad Sci USA 1997;94:9372-7. (Pubitemid 27357836)
23. Ruder EH, Dorgan JF, Kranz S, Kris-Etherton PM, Hartman TJ. Examining breast cancer growth and lifestyle risk factors: Early life, childhood, and adolescence. Clin Breast Cancer 2008;8:334-42.
24. Golub MS, Collman GW, Foster PM, Kimmel CA, Rajpert-De Meyts E, Reiter EO, et al. Public health implications of altered puberty timing. Pediatrics 2008;121:S218-30.
25. Lilienthal H, Hack A, Roth-Hrer A, Grande SW, Talsness CE. Effects of developmental exposure to 2,2,4,4,5-pentabromodiphenyl ether (PBDE-99) on sex steroids, sexual development, and sexually dimorphic behavior in rats. Environ Health Perspect 2006;114:194-201. (Pubitemid 43193639)
26. Fernndez M, Bianchi M, Lux-Lantos V, Libertun C.Neonatal exposure to bisphenol a alters reproductive parameters and gonadotropin releasing hormone signaling in female rats. Environ Health Perspect. 2009.117.757-62.
27. Wolff MS, Britton JA, Boguski L, Hochman S, Maloney N, Serra N, et al. Environmental exposures and puberty in inner-city girls. Environ Res 2008;107:393-400.
28. Den Hond E, Schoeters G. Endocrine disrupters and human puberty. Int J Androl 2006;29:264-71.
29. Hilakivi-Clarke L. Nutritional modulation of terminal end buds: Its relevance to breast cancer prevention. Curr Cancer Drug Targets 2007;7:465-74. (Pubitemid 47196206)
30. Fenton SE, Hamm JT, Birnbaum LS, Youngblood GL. Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 2002;67:63-74. (Pubitemid 34520810)
31. Szeto IM, Aziz A, Das PJ, Taha AY, Okubo N, Reza-Lopez S, et al. High multivitamin intake by Wistar rats during pregnancy results in increased food intake and components of the metabolic syndrome in male offspring. Am J Physiol Regul Integr Comp Physiol 2008;295:R575-82.
32. Schedin P, Mitrenga T, Kaeck M. Estrous cycle regulation of mammary epithelial cell proliferation, differentiation, and death in the Sprague-Dawley rat: A model for investigating the role of estrous cycling in mammary carcinogenesis. J Mammary Gland Biol Neoplasia 2000;5:211-25. (Pubitemid 32045697)
33. de Assis S, Khan G, Hilakivi-Clarke L. High birth weight increases mammary tumorigenesis in rats. Int J Cancer 2006;119:1537-46. (Pubitemid 44258758)
34. Walker BE. Tumors in female offspring of control and diethylstilbestrol- exposed mice fed high-fat diets. J Natl Cancer Inst 1990;82:50-4. (Pubitemid 20020894)
35. Luijten M, Thomsen AR, van den Berg JA, Wester PW, Verhoef A, Nagelkerke NJ, et al. Effects of soy-derived isoflavones and a high-fat diet on spontaneous mammary tumor development in Tg.NK (MMTV/c-neu) mice. Nutr Cancer 2004;50:46-54. (Pubitemid 39587605)
36. Medina D. Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens. J Mammary Gland Biol Neoplasia 2008;13:271-7.
37. Newbold RR, Jefferson WN, Padilla-Banks E, Haseman J. Developmental exposure to diethylstilbestrol (DES) alters uterine response to estrogens in prepubescent mice: Low versus high dose effects. Reprod Toxicol 2004;18:399-406. (Pubitemid 38479875)
38. Alworth LC, Howdeshell KL, Ruhlen RL, Day JK, Lubahn DB, Huang TH, et al. Uterine responsiveness to estradiol and DNA methylation are altered by fetal exposure to diethylstilbestrol and methoxychlor in CD-1 mice: Effects of low versus high doses. Toxicol Appl Pharmacol 2002;183:10-22.
39. Nagata C, Nagao Y, Shibuya C, Kashiki Y, Shimizu H. Urinary cadmium and serum levels of estrogens and androgens in postmenopausal Japanese women. Cancer Epidemiol Biomarkers Prev 2005;14:705-8. (Pubitemid 40489218)
40. Cops EJ, Bianco-Miotto T, Moore NL, Clarke CL, Birrell SN, Butler LM, et al. Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors. J Steroid Biochem Mol Biol 2008;110:236-43.
41. Birrell SN, Butler LM, Harris JM, Buchanan G, Tilley WD. Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer. FASEB J 2007;21:2285-93. (Pubitemid 47230658)
42. Shufelt CL, Braunstein GD. Testosterone and the breast. Menopause Int 2008;14:117-22.
43. Hickey TE, Robinson JL, Carroll JS, Tilley WD. Minireview: The androgen receptor in breast tissue: growth inhibitor, tumor suppressor, oncogene? Mol Endocrinol 2012:26:1252-67.
44. Macedo LF, Guo Z, Tilghman SL, Sabnis GJ, Qiu Y, Brodie A. Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole. Cancer Res 2006;66:7775-82. (Pubitemid 44289238)
45. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005;97:755-65. (Pubitemid 40879595)
46. Hankinson SE, Eliassen AH. Circulating sex steroids and breast cancer risk in premenopausal women. Horm Cancer 2010;1:2-10.
47. Dorgan JF, Stanczyk FZ, Kahle LL, Brinton LA. Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk. Breast Cancer Res 2010;12:R98.
48. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004;96:1856-65. (Pubitemid 40081323)
49. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: The European prospective investigation into cancer and nutrition. Endocr Relat Cancer 2005;12:1071-82. (Pubitemid 41815798)
50. Sieri S, Krogh V, Bolelli G, Abagnato CA, Grioni S, Pala V, et al. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: The ORDET cohort. Cancer Epidemiol Biomarkers Prev 2009;18:169-76.
51. Khan SA, Rogers MA, Khurana KK, Meguid MM, Numann PJ. Estrogen receptor expression in benign breast epithelium and breast cancer risk. J Natl Cancer Inst 1998;90:37-42. (Pubitemid 28078079)
52. Lagiou P, Georgila C, Samoli E, Lagiou A, Zourna P, Minaki P, et al. Estrogen alpha and progesterone receptor expression in the normal mammary epithelium in relation to breast cancer risk. Int J Cancer 2009;124:440-2.
53. Russo J, Wilgus G, Russo IH. Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am J Pathol 1979;96:721-36. (Pubitemid 10234678)
54. Russo J, Russo IH. Toward a unified concept of mammary carcinogenesis. In: Aldaz MC, Gould MN, McLachlan J, Slaga TJ, editors. Progress in Clinical and Biological Research. New York: Wiley-Liss; 1997. p. 1-16.
55. Hilakivi-Clarke L, Cho E, Raygada M, Kenney N. Alterations in mammary gland development following neonatal exposure to estradiol, transforming growth factor alpha, and estrogen receptor antagonist ICI 182,780. J Cell Physiol 1997;170:279-89. (Pubitemid 27117912)
56. Roy JR, Chakraborty S, Chakraborty TR. Estrogen-like endocrine disrupting chemicals affecting puberty in humans-a review. Med Sci Monit 2009:15:RA137-45.
57. Schoeters G, Den Hond E, Dhooge W, van Larebeke N, Leijs M. Endocrine disruptors and abnormalities of pubertal development. Basic Clin Pharmacol Toxicol 2008:102:168-75 (Pubitemid 351143431)
58. Newbold RR, Padilla-Banks E, Jefferson WN, Heindel JJ. Effects of endocrine disruptors on obesity. Int J Androl 2008;31:201-8.